Paradigm Biopharmaceuticals Ltd
F:P86
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Paradigm Biopharmaceuticals Ltd
F:P86
|
AU |
|
C
|
Celestica Inc
DUS:CTW
|
CA |
|
Bank Rakyat Indonesia (Persero) Tbk PT
IDX:BBRI
|
ID |
|
Blackmores Ltd
ASX:BKL
|
AU |
|
C
|
Carter's Inc
XMUN:HCH
|
US |
|
Himax Technologies Inc
NASDAQ:HIMX
|
TW |
|
R
|
Relx PLC
DUS:RDEB
|
UK |
|
E
|
EVN AG
VSE:EVN
|
AT |
|
B
|
Balchem Corp
SWB:BL9B
|
US |
|
E
|
Eli Lilly and Co
DUS:LLY
|
US |
|
R
|
Redbubble Ltd
OTC:RDBBF
|
AU |
|
S
|
Sarepta Therapeutics Inc
XMUN:AB3A
|
US |
Bankruptcy Probability
Paradigm Biopharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Paradigm Biopharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
70.7m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
379.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Paradigm Biopharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Paradigm Biopharmaceuticals Ltd has total debt of 9.2m AUD. This includes both short-term (8.8m AUD) and long-term (436.8k AUD) debt.
You can find a full breakdown on its Balance Sheet.
